Screening Test Review Committee Report 2026, Volume 1

Singapore’s Screening Test Review Committee (STRC) Report 2026, Volume 1 provides expert guidance to healthcare practitioners on appropriate use of selected screening tests, based on current evidence. MOH published the volume on 3 February 2026, noting that the previous STRC report was published in 2019 and that the recommendations were refreshed for evolving evidence, disease epidemiology and Singapore’s population (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026). The report is clinical guidance, not a self-diagnosis tool or a promise that every test is suitable for every person.

Conditions covered in Volume 1

Volume 1 covers refreshed screening recommendations for breast, cervical, colorectal and lung cancer, as well as diabetes mellitus, hyperlipidaemia, hypertension, obesity and osteoporosis—nine named screening areas in total (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026). The public MOH page identifies the conditions covered but does not reproduce every recommendation, eligibility threshold or follow-up pathway. Those details should be taken from the report itself and interpreted by a qualified healthcare practitioner in the patient’s clinical context.

The list describes the scope of the volume, not a recommendation that every person should undergo all nine types of screening. The relevant report chapter, a clinician’s assessment and the person’s risk profile determine which guidance is applicable (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026).

Committee role and report status

MOH describes STRC as a committee established to provide expert guidance to healthcare practitioners on the appropriate use of specific screening tests in Singapore. The 2026 report is being published in two volumes, and Volume 1 is the published volume covering the nine named areas above. The volume number is therefore a publication boundary, not a count of tests, diagnoses, or eligible population groups. The page also frames the recommendations as part of preventive-care and primary-care efforts aligned with Healthier SG; it does not announce a new regulator, a new offence or a universal screening entitlement (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026).

Primary-care and personalised assessment

MOH says screening is most effective when conducted in a primary-care setting where a doctor can provide personalised advice, explain results and ensure follow-up. The ministry advises against relying on mass-screening events that may not provide adequate individualised assessment or follow-through support (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026). This guidance does not mean that every mass event is clinically inappropriate; it explains why screening decisions and abnormal results should connect to a healthcare provider.

Primary care is therefore the decision and follow-up context, not merely a venue for collecting a test sample. A clinician can interpret the result alongside symptoms, history and risk, explain what happens next, and avoid presenting a screening result as a diagnosis (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026).

How to interpret the report

The STRC recommendations support preventive care and inform Singapore’s screening policies, but they do not replace clinical judgement. Screening eligibility can depend on factors such as age, sex, symptoms, personal and family history, risk exposure and previous results; a general list of conditions cannot determine an individual’s care plan. The 2026 report should also not be conflated with a new national screening entitlement, a universal free-test programme or a diagnosis (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026).

For retrieval purposes, “recommended screening” and “diagnostic testing” should remain distinct. Screening generally concerns people without a confirmed diagnosis, while a clinician may order diagnostic work-up because of symptoms, examination findings or an abnormal screening result; this article does not infer a personal recommendation from the committee’s topic list (MOH, STRC Report 2026 Volume 1, accessed 8 September 2026).